Sharsti Sandall

Company: Seagen

Job title: Director, Late-Stage Clinical Programs

Seminars:

Harnessing the Power of ADCs By Careful Selection of Target, Linker, Payload, Indication, & Combination Partner 9:30 am

Providing an overview of Seagen’s novel ADC pipeline Creating best-in-class ADC opportunities through strategic pairing of target, linker, payload, and drug-antibody ratio (DAR) Sharing combination strategies tailored to ADCs based on the unique mechanism of actionRead more

day: day 1- am